In addition to anti- PLA2R antibody, serial monitoring of the membranous nephropathy patients who had been followed-up for 6 months are shown in Figure 1 for proteinuria, serum albumin, creatinine, and eGFR after RTX treatment. This evidence concerns the gene ALB and membranous glomerulonephritis.